$SATT

SATIVUS TECH CORP.

CIK:0001661600|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Operating expenses:
Research and development	$ (95)	$ (122)	$ (172)	$ (328)
General and administrative	(63)	(91)	(134)	(145)
Operating loss	(158)	(213)	(306)	(473)
Financial income (expenses), net	116	(209)	12	(47)
Net loss	(42)	(422)	(294)	(520)
Non-controlling interests	(62)	(90)	(120)	(187)
Net loss attributable to equity holders of the Company	$ 20	$ (332)	$ (174)	$ (333)
Basic net loss per share attributable to equity holders of the Company	$ (0.00)	$ (0.08)	$ (0.04)	$ (0.08)
Diluted net loss per share attributable to equity holders of the Company	$ (0.00)	$ (0.08)	$ (0.04)	$ (0.08)
Weighted average number of ordinary shares used in computing basic loss per share	4,215,571	4,215,571	4,215,571	4,215,571
Weighted average number of ordinary shares used in computing diluted loss per share	4,215,571	4,215,571	4,215,571	4,215,571

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net income (loss)	$ (294)	$ (520)
Adjustments to reconcile loss to net cash used in operating activities:
Depreciation and amortization	40	80
Share based compensation expenses to employees and non-employees	0	15
Financial expenses related to convertible loans and warrants	81	85
Change in fair value of convertible component in convertible loans	(108)	(75)
Changes in assets and liabilities:
Decrease (Increase) in other accounts receivable	32	6
Increase in accounts receivable	21	(4)
Decrease (Increase) in trade payables	30	216
Decrease (Increase) in other accounts payables	25	126
Net cash used in operating activities	(173)	(86)
Cash flows from investing activities:
Purchase of property and equipment, Net	0	0
Decrease (increase) in restricted cash	(1)	5
Proceeds Loans from related party	27	74
Proceeds from Short term loans	0	78
Decrease (increase) in deposits	0	0
Net cash used in investing activities	26	157
Cash flows from financing activities:
Lease payments	0	0
Proceeds from convertible loans	0	36
Proceeds from issuance of shares to minority interests in subsidiary	200	38
Net cash provided (used) by financing activities	200	74
Increase (decrease) in cash and cash equivalents and restricted cash	53	145
Cash and cash equivalents and restricted cash at the beginning of the year	32	96
Cash and cash equivalents at the end of the period	$ 85	$ 241

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
CURRENT ASSETS:
Cash and cash equivalents	$ 85	$ 32
Restricted cash	10	9
Accounts receivable	0	21
Prepaid expenses and other receivables	9	41
Total current assets	104	103
NON-CURRENT ASSETS
Property and equipment, net	164	204
Total non-current assets	164	204
Total assets	268	307
CURRENT LIABILITIES
Accounts payables	297	267
Convertible loans	2,532	2,451
Loans from related party	125	98
Fair value of convertible component in convertible loans	618	726
Other accounts liabilities	321	296
Total current liabilities	3,893	3,838
SHAREHOLDERS’ DEFICIT
Ordinary shares of $0.0001 par value Authorized: 500,000,000 shares at June 30, 2026 and December 31, 2025; Issued and Outstanding: 4,215,571 and 4,215,571 shares at June 30, 2026 and December 31, 2025, respectively	4	4
Additional Paid in capital	21,083	20,973
Accumulated deficit	(24,652)	(24,477)
Shareholders’ deficit	(3,565)	(3,500)
Non-controlling interests	(60)	(31)
Total shareholders’ deficit	(3,625)	(3,531)
Total liabilities and shareholders’ deficit	$ 268	$ 307